BPAG1 Activators
BPAG1, also known as DST, is a cytoskeletal linker protein critical for maintaining the structural integrity and function of various tissues. Its activity and stability are influenced by the dynamic cellular environment, including the cytoskeletal architecture, cell signaling pathways, and gene expression profiles. Compounds such as Taxol and Colchicine, which affect microtubule dynamics, could indirectly impact the function of BPAG1 by altering the cytoskeletal framework and potentially influencing the mechanical and signaling interactions involving BPAG1. Changes in the cytoskeletal organization might demand compensatory or adaptive responses in the function or expression of BPAG1, reflecting its role in maintaining cellular integrity. Similarly, agents that modulate gene expression, such as Retinoic Acid, all trans and Histone Deacetylase Inhibitors, might influence BPAG1 by altering the transcriptional landscape, leading to changes in the expression of BPAG1 itself or its associated proteins.
Furthermore, the cellular response to external and internal signals, mediated by compounds like Cholecalciferol and EGF, might also modulate BPAG1 activity. These agents can influence cell proliferation, differentiation, and stress responses, processes in which BPAG1 is potentially involved, especially in skin cells and neurons. Modulating these pathways could lead to altered demands or regulatory mechanisms for BPAG1, reflecting its integration into a complex network of cellular responses. Additionally, the stability and turnover of BPAG1, influenced by agents like Proteasome Inhibitors or Lithium Chloride, could affect its availability and function in the cell. By understanding and potentially modulating these indirect pathways, there is a possibility to influence the role of BPAG1 in diseases like bullous pemphigoid, hereditary sensory, and motor neuropathy, and potentially other conditions where cytoskeletal integrity and signaling are disrupted. Each of these compounds represents a possible avenue through which the activity or expression of BPAG1 might be modulated, reflecting the interplay of multiple signaling pathways, structural dynamics, and regulatory mechanisms essential for maintaining cellular structure and function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Taxol stabilizes microtubules and can affect cytoskeletal dynamics. By altering the cytoskeletal network, it might influence the cellular context in which BPAG1 operates, potentially affecting its function or stability. | ||||||
Colchicine | 64-86-8 | sc-203005 sc-203005A sc-203005B sc-203005C sc-203005D sc-203005E | 1 g 5 g 50 g 100 g 500 g 1 kg | $100.00 $321.00 $2289.00 $4484.00 $18207.00 $34749.00 | 3 | |
Colchicine binds to tubulin and inhibits microtubule polymerization, affecting cytoskeletal organization. Changes in microtubule dynamics could indirectly affect BPAG1's role in linking intermediate filaments to microtubules. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid, all trans influences cell differentiation and apoptosis and affects the expression of a wide range of genes. It may influence BPAG1 activity indirectly by altering cellular differentiation pathways or gene expression profiles. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $71.00 $163.00 $296.00 | 2 | |
Cholecalciferol has roles in cell proliferation, differentiation, and apoptosis. It might affect BPAG1 activity indirectly by modulating cell cycle dynamics and differentiation status, especially in skin cells. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
These inhibitors can lead to a more relaxed chromatin structure and affect gene expression. They may increase BPAG1 expression or alter its activity by changing the acetylation status of histones around its target genes or regulatory regions. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
By inhibiting DNA methyltransferases, these compounds can lead to demethylation and reactivation of silenced genes. They might indirectly enhance BPAG1 expression by changing the epigenetic state of its gene or regulatory regions. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Proteasome inhibitors like MG-132 [Z-Leu- Leu-Leu-CHO] increase the levels of ubiquitinated proteins and can lead to stress responses. This might indirectly influence the activity or stability of BPAG1 by altering the cellular environment and protein turnover. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium is known to inhibit GSK-3β, a kinase involved in numerous signaling pathways. By modulating pathways associated with GSK-3β, Lithium Chloride might indirectly affect the signaling context and activity of BPAG1. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin affects various cellular processes, including inflammation and apoptosis, and might modulate BPAG1 activity by influencing these pathways or affecting the expression of genes regulated by BPAG1. | ||||||